Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38
The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard (ETS) requiring the vaccination of all employees of companies with more than 100 employees.
AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate.
PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended September 30, 2021.
Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease
Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease
Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations
PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases
Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).
Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S. law firm to plant a flag in the tech-heavy region sometimes called “Silicon Slopes.”
Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on recent business performance and strategic transformation plans.
12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.